Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Steinar Engelsen Insider Profile
4 Followers
Steinar Engelsen, Director at Insmed, holds 320.80K shares in Insmed (Ticker: INSM), holds 41.83K shares in Soleno Therapeutics (Ticker: SLNO). Most recently, Steinar Engelsen Bought ― shares of Insmed on Nov 03, 2021 for an estimated value of 429.04K.
Profitable Transactions
2 out of 7 Profitable Transactions
Average Return
-20.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Steinar Engelsen holds in companies
Most Profitable Insider Trade
The most profitable trade made by Steinar Engelsen
Steinar Engelsen's Trading History
Insmed
Nov 03, 2021
Director
Informative Buy
429.04K
$7.93M
Soleno Therapeutics
Feb 07, 2018
Director
Uninformative Buy
13.95K
$1.87M
List of latest transactions for each holding click on a transaction to see Steinar Engelsen's performance on stock
You May Also Like
Steinar Engelsen insider profile FAQ
What is the percentage of profitable transactions made by Steinar Engelsen?
The percentage of profitable transactions made by Steinar Engelsen is 29%.
What is the average return per transaction made by Steinar Engelsen?
The average return per transaction made by Steinar Engelsen is -20.90%.
What stocks does Steinar Engelsen hold?
Steinar Engelsen holds: INSM, SLNO stocks.
What was Steinar Engelsen’s latest transaction?
Steinar Engelsen latest transaction was an Informative Buy of $429.04K.
What was Steinar Engelsen's most profitable transaction?
Steinar Engelsen’s most profitable transaction was an Informative Buy of INSM stock on May 6, 2014. The return on the trade was 51.50%.
What is Steinar Engelsen's role in Insmed?
Steinar Engelsen's role in Insmed is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.